We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+11.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$10.6B
AUM Growth
+$1.17B
(+12%)
Cap. Flow
+$3.01B
Cap. Flow
% of AUM
28.27%
Top 10 Holdings %
Top 10 Hldgs %
22.3%
Holding
850
New
52
Increased
273
Reduced
342
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$96.9M |
| 2 |
Merck
MRK
|
+$73.5M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$57.1M |
| 4 |
Illumina
ILMN
|
+$40.4M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$34.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$57.2M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
+$51.7M |
| 3 |
Kimberly-Clark
KMB
|
+$28.5M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
+$26.5M |
| 5 |
Arista Networks
ANET
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.77% |
| 2 | Technology | 20.35% |
| 3 | Consumer Discretionary | 9.49% |
| 4 | Communication Services | 7.69% |
| 5 | Financials | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Kinder Morgan
KMI
$70.5B
| $6.68M | 0.06% |
542,169
+4,457
| +0.8% | +$62.1K |
|
302
SLB Ltd
SLB
$72.6B
| $6.68M | 0.06% |
429,665
+17,165
| +4% | +$319K |
|
303
Agilent Technologies
A
$39.2B
| $6.63M | 0.06% |
65,657
+23,185
| +55% | +$2.24M |
|
304
Veracyte
VCYT
$4.77B
| $6.58M | 0.06% |
202,595
-6,420
| -3% | -$204K |
|
305
Gen Digital
GEN
$16.3B
| $6.57M | 0.06% |
315,324
-47,895
| -13% | -$1.04M |
|
306
AstraZeneca
AZN
$266B
| $6.53M | 0.06% |
59,553
+32,210
| +118% | +$3.58M |
|
307
Pfizer
PFE
$142B
| $6.51M | 0.06% |
187,111
+11,127
| +6% | +$390K |
|
308
HCA Healthcare
HCA
$85.7B
| $6.44M | 0.06% |
51,655
-81,539
| -61% | -$10.1M |
|
309
D.R. Horton
DHI
$40.7B
| $6.42M | 0.06% |
84,857
-22,368
| -21% | -$1.53M |
|
|
SJR
310
DELISTED
Shaw Communications Inc.
SJR
| $6.38M | 0.06% |
350,925
+211,122
| +151% | +$3.85M |
|
311
DexCom
DXCM
$28.8B
| $6.38M | 0.06% |
61,860
-24
| -0% | -$2.51K |
|
312
Chipotle Mexican Grill
CMG
$49.4B
| $6.3M | 0.06% |
253,500
+186,850
| +280% | +$4.5M |
|
313
Hartford Financial Services
HIG
$39.2B
| $6.16M | 0.06% |
166,990
+52,274
| +46% | +$2.08M |
|
|
CETV
314
DELISTED
Central European Media Enterprises Ltd
CETV
| $6.08M | 0.06% |
1,450,357
| – | – |
|
315
DuPont de Nemours
DD
$18.7B
| $6.07M | 0.06% |
87,104
-46,569
| -35% | -$3.26M |
|
316
Wells Fargo
WFC
$258B
| $6.04M | 0.06% |
257,077
-11,497
| -4% | -$283K |
|
317
Kroger
KR
$35.4B
| $6.04M | 0.06% |
178,033
+102,583
| +136% | +$3.54M |
|
318
ZTO Express
ZTO
$18.1B
| $6.02M | 0.06% |
201,199
-333,600
| -62% | -$11.4M |
|
319
McKesson
MCK
$101B
| $5.99M | 0.06% |
40,247
+2,045
| +5% | +$310K |
|
320
American International
AIG
$41.8B
| $5.94M | 0.06% |
215,727
+156,064
| +262% | +$4.65M |
|
321
Equitable Holdings
EQH
$13.3B
| $5.91M | 0.06% |
323,835
+5,341
| +2% | +$107K |
|
322
Toronto Dominion Bank
TD
$198B
| $5.83M | 0.05% |
126,380
+640
| +0.5% | +$29.8K |
|
|
MRSH
323
Marsh
MRSH
$91.4B
| $5.72M | 0.05% |
49,834
+1,726
| +4% | +$198K |
|
324
KLA
KLAC
$236B
| $5.7M | 0.05% |
294,260
-8,480
| -3% | -$168K |
|
325
Aprea Therapeutics
APRE
$7.86M
| $5.63M | 0.05% |
11,693
+5,154
| +79% | +$2.88M |
|
Similar funds
PCM
A
MGP
LF
BPA
MIM
SPIA
Candriam SCA's Q3 2020 Portfolio in Review
As of Q3 2020, Candriam SCA held 850 positions worth $10.6B, up 12% from $9.47B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $3.01B of net new capital in Q3 2020, opening 52 new positions and adding to 273 existing holdings. Its largest new stake was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $57.2M trimmed.
- Candriam SCA's largest Q3 2020 buy was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
- Candriam SCA added most to Amgen in Q3 2020, an estimated $96.9M increase.
- Candriam SCA's biggest Q3 2020 reduction was Apple, cutting an estimated $57.2M.
- Candriam SCA fully exited G1 Therapeutics, Inc. Common Stock in Q3 2020, selling an estimated $21.1M.
- Candriam SCA's ten largest holdings make up 22% of its $10.6B portfolio in Q3 2020.
- Candriam SCA opened 52 new positions and closed 48 in Q3 2020.
- Candriam SCA's portfolio value rose 12% quarter-over-quarter to $10.6B.
Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.